Recombinant lymphocytic choriomeningitis virus expressing vesicular stomatitis virus glycoprotein. - Wikidata - awgldk - TriplyDB

Recombinant lymphocytic choriomeningitis virus expressing vesicular stomatitis virus glycoprotein.

Recombinant lymphocytic choriomeningitis virus expressing vesicular stomatitis virus glycoprotein.

http://www.wikidata.org/entity/Q35147223

about

Arenavirus reverse genetics: new approaches for the investigation of arenavirus biology and development of antiviral strategies A multivalent vaccination strategy for the prevention of Old World arenavirus infection in humans Reporter-Expressing, Replicating-Competent Recombinant Arenaviruses Junín virus pathogenesis and virus replication Envelope exchange for the generation of live-attenuated arenavirus vaccines Targeting the proteolytic processing of the viral glycoprotein precursor is a promising novel antiviral strategy against arenaviruses.RNA polymerase I-driven minigenome system for Ebola viruses.Novel approaches in anti-arenaviral drug development Evolution of recombinant lymphocytic choriomeningitis virus/Lassa virus in vivo highlights the importance of the GPC cytosolic tail in viral fitness.Junín virus infection activates the type I interferon pathway in a RIG-I-dependent manner Antiviral activity of a small-molecule inhibitor of arenavirus glycoprotein processing by the cellular site 1 protease."Viral déjà vu" elicits organ-specific immune disease independent of reactivity to self.Recovery of an arenavirus entirely from RNA polymerase I/II-driven cDNA Reverse genetics approaches to combat pathogenic arenaviruses Development of replication-defective lymphocytic choriomeningitis virus vectors for the induction of potent CD8+ T cell immunity.Identification and Mechanism of Action of a Novel Small-Molecule Inhibitor of Arenavirus Multiplication.Evaluation of the anti-arenaviral activity of the subtilisin kexin isozyme-1/site-1 protease inhibitor PF-429242.Arenavirus Glycan Shield Promotes Neutralizing Antibody Evasion and Protracted Infection.Lassa virus.Lassa Virus Cell Entry via Dystroglycan Involves an Unusual Pathway of Macropinocytosis.Brain-resident memory T cells represent an autonomous cytotoxic barrier to viral infection Role of DC-SIGN in Lassa virus entry into human dendritic cells Kinetics of protective antibodies are determined by the viral surface antigen.Reverse Genetics Approaches to Control Arenavirus.Development of live-attenuated arenavirus vaccines based on codon deoptimization of the viral glycoprotein.Myristoylation of the RING finger Z protein is essential for arenavirus budding Inhibition of the type I interferon antiviral response during arenavirus infection.Cell entry of lymphocytic choriomeningitis virus is restricted in myotubes.Replicon system for Lassa virus.Sodium hydrogen exchangers contribute to arenavirus cell entry.Efficient reverse genetics generation of infectious junin viruses differing in glycoprotein processing.Different mechanisms of cell entry by human-pathogenic Old World and New World arenaviruses.Development of Recombinant Arenavirus-Based Vaccines.T regulatory cells are critical for the maintenance, anamnestic expansion and protection elicited by vaccine-induced CD8 T cells.Innate and adaptive immune control of genetically engineered live-attenuated arenavirus vaccine prototypes.A cell-based luciferase assay amenable to high-throughput screening of inhibitors of arenavirus budding.Genetic and biochemical evidence for an oligomeric structure of the functional L polymerase of the prototypic arenavirus lymphocytic choriomeningitis virus Generation of Lymphocytic Choriomeningitis Virus Based Vaccine Vectors.Inhibition of the type I interferon response by the nucleoprotein of the prototypic arenavirus lymphocytic choriomeningitis virus Studies of Lassa Virus Cell Entry.

P2860

Q24599295-F6C54025-1198-484D-9376-2C1E7F31CB94 Q24611383-132E43C3-2E15-4934-899C-2A2C44D3E7CC Q26742028-4F76688E-C652-4E4D-8AE2-4340E579D4A0 Q26992011-EF35FAC7-2343-4078-B069-1B7F44905A5D Q27320211-D6697C32-5297-4738-938C-FCBD1B6FAD31 Q33558767-1D77C75C-398E-46AD-97AD-A74D93437730 Q33707432-8AD2DBD8-5F8A-4C92-AB93-A97A1D8ED6B3 Q33779739-B15910A4-C4DB-4CBB-9F1F-E747E5EB1964 Q34057974-95AA330E-E767-4DD9-9B95-08554A2601CB Q34282240-1F04F471-B17F-4148-BA8A-E38236B0AF1D Q34485294-6ADEE5A3-BF76-4D11-BA4F-69D06E66F51E Q34520218-BA8C0692-DFB3-430C-8690-2CD2D42C1DD5 Q34574914-F43B6234-2B8C-4204-B4FB-8D24F34872FC Q34596958-524B81F3-95B8-4F38-9140-29F316D8939F Q35638608-AA04E83C-3FA4-4DE1-8FCC-D5EDE60D119C Q35751585-2F3B63A6-8F8D-49C6-81A9-22DA4A3D0CED Q35774829-C9E91FCA-C305-403D-BA86-24560560B874 Q35847032-DDB2212D-815D-4229-BEA4-F17ACF4E7CB1 Q35919691-7F2FBCC1-8209-403C-B34C-100C7C276CA5 Q37073355-B979280C-3A2C-4EC2-827B-C5A62839143A Q37179031-34FFA55C-E960-412B-8A44-F7E307325D46 Q37252717-2BBFD045-3968-4C81-B242-45D0711CD255 Q37532751-4CB5FFDD-D901-442E-9856-E3F961D0A297 Q37543755-56311954-DB45-4D25-85AB-5437903709BA Q37546745-81E7F6AC-E013-4014-96C4-0FA9FD80DF6E Q37568060-2354ECA5-0D97-4C28-8398-2EE899A82438 Q37945195-D9A9E102-8243-4147-873B-0F70C5EBF1BD Q38985001-F23CD1D8-C83B-40A6-9816-8E81D2C47CDB Q39052889-FDF1895D-2411-472A-B4A1-9A1428AF001F Q39068701-B083D9A2-5CFE-484C-AB98-8CE303F152CB Q39868272-1BFD0578-4E81-49B7-A7C5-CB589A9160C2 Q39977616-D2491B02-C3B0-48E6-9970-6D3E0DD73469 Q40259618-EC676873-9B1F-4CCC-AA2E-37B729F719E0 Q40291652-CF8754DB-1B25-49FC-A757-F6728ACC64A9 Q40355385-E81536EE-347D-425D-B47E-7A6E1C9C492E Q40407065-E80D41C5-DF66-420B-A2F6-05B0C0266233 Q40423159-E1462C21-45DE-41CF-AF35-65D773D4308E Q40715549-CB686A77-F48B-4078-AD1F-82A2969D3F4F Q41847342-4861F19C-E2C0-46A2-9A72-DC3668271FA0 Q41922444-0C89E9AF-D598-4B65-8BA8-C8B4EA943399

P2860

Recombinant lymphocytic choriomeningitis virus expressing vesicular stomatitis virus glycoprotein.

http://www.wikidata.org/entity/Q35147223

description

2003 nî lūn-bûn

@nan

2003 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2003 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

name

Recombinant lymphocytic chorio ...... stomatitis virus glycoprotein.

@ast

Recombinant lymphocytic chorio ...... stomatitis virus glycoprotein.

@en

type

label

Recombinant lymphocytic chorio ...... stomatitis virus glycoprotein.

@ast

Recombinant lymphocytic chorio ...... stomatitis virus glycoprotein.

@en

prefLabel

Recombinant lymphocytic chorio ...... stomatitis virus glycoprotein.

@ast

Recombinant lymphocytic chorio ...... stomatitis virus glycoprotein.

@en

P1433

Q35147223-DFBF9B8D-ACE5-43B0-A418-B2D488EA5798

P1476

Q35147223-B39DBD08-1101-4CF6-B5AE-3EC23B4E0647

P2093

Q35147223-0167392C-FB85-46A9-AA1B-A05172B4EB45

Q35147223-1BA0E37C-C388-4A87-B588-E02D62D9D427

Q35147223-4770249A-4488-42F4-A77C-F002DE532F7E

Q35147223-DF037688-690C-48D8-8EAB-C635940DF5AE

P2860

Q35147223-0195BB52-FE0D-4304-9DA0-E841E7045E9C

Q35147223-0D75D1EF-37F5-4527-9119-7B1D70B99834

Q35147223-116B348E-D18A-4E3B-A8D3-5710B50F497D

Q35147223-128166B4-FB75-4B1B-9806-3BBA2F5E31CC

Q35147223-22393B21-2EFF-4AC7-BB0A-34DA83EC13B9

Q35147223-34ED0286-E849-43BB-8925-A6C5DB1D55C6

Q35147223-3F5381C9-6808-44DF-ABA0-0B648E471F54

Q35147223-41FC27F4-B43E-40E4-8EB9-3DDBC4D09A85

Q35147223-4F9820DA-B3A3-4591-AA8D-089F4A451672

Q35147223-5BDD9CA3-01F3-49C9-BBCD-E4C938374751

P304

Q35147223-D968097C-3272-4A47-8E8F-E8D2B3424729

P31

Q35147223-0430E691-1A73-44EE-9BBB-FA0147BBD657

P356

Q35147223-AF60D42A-6D75-48BB-BB04-F80D664C5AB8

P407

Q35147223-F899D20A-81FB-42A8-A910-A1F3702A5DB7

P433

Q35147223-7DA965A0-2A75-46E0-B88E-473E062A20C0

P478

Q35147223-E9308654-1E1E-41D1-B1E3-3DC2E61426C6

P577

Q35147223-90A2BD88-B5D0-400D-A171-2293910A3D4D

P5875

Q35147223-ECB5111A-BD84-4E48-82C0-50D092BBE662

P698

Q35147223-D4312CCF-DFC5-49A5-B3D1-3B62E8A6BAC2

P921

Q35147223-32F64C5E-078F-4E46-804C-C113A64F8C9F

P932

Q35147223-39DD72D5-1AA5-4202-8CBF-E84A76605510

P356

PNAS.1332709100

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Recombinant lymphocytic chorio ...... stomatitis virus glycoprotein.

@en

P2093

Ana B Sanchez

http://www.w3.org/2001/XMLSchema#string

Daniel D Pinschewer

http://www.w3.org/2001/XMLSchema#string

Juan Carlos de la Torre

http://www.w3.org/2001/XMLSchema#string

Mar Perez

http://www.w3.org/2001/XMLSchema#string

P2860

NP and L proteins of lymphocytic choriomeningitis virus (LCMV) are sufficient for efficient transcription and replication of LCMV genomic RNA analogs

N-terminal domain of Borna disease virus G (p56) protein is sufficient for virus receptor recognition and cell entry

Chimeric measles viruses with a foreign envelope

Reverse genetics system for Uukuniemi virus (Bunyaviridae): RNA polymerase I-catalyzed expression of chimeric viral RNAs

Protein structure of lymphocytic choriomeningitis virus: evidence for a cell-associated precursor of the virion glycopeptides.

The Lassa virus glycoprotein precursor GP-C is proteolytically processed by subtilase SKI-1/S1P.

RING finger Z protein of lymphocytic choriomeningitis virus (LCMV) inhibits transcription and RNA replication of an LCMV S-segment minigenome.

Arenaviruses: genomic RNAs, transcription, and replication.

A decade after the generation of a negative-sense RNA virus from cloned cDNA - what have we learned?

Oncoretrovirus and lentivirus vectors pseudotyped with lymphocytic choriomeningitis virus glycoprotein: generation, concentration, and broad host range

P304

7895-7900

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.1332709100

http://www.w3.org/2001/XMLSchema#string

P407

P433

13

http://www.w3.org/2001/XMLSchema#string

P478

100

http://www.w3.org/2001/XMLSchema#string

P577

2003-06-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

10707285

http://www.w3.org/2001/XMLSchema#string

P698

12808132

http://www.w3.org/2001/XMLSchema#string

P921

P932

164684

http://www.w3.org/2001/XMLSchema#string